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Over the recent years, there is growing interest in the potential benefit of tea in cardio-
vascular protection. Tea is the extract of Camellia sinensis, and one of the most widely 
enjoyed drinks. The leaves of the plant are rich in flavonoids, among which catechins 
predominate in green tea and thearubigins in black tea, with purported potent anti-
oxidant, free radical scavenging, appetite-modifying and hypolipidemic and hypoten-
sive effects, mechanisms which all lead to cardiovascular protection. Data supporting 
these favorable effects of tea on the cardiovascular system are herein briefly reviewed.
A variety of dietary supplements have been proposed for the management of 
hypertension and other cardiovascular diseases, but the evidence for their efficacy is 
meagre.1 However, over the last few years, there is growing interest in the potential 
benefit of tea in cardiovascular protection.2-4 Tea is the extract of Camellia sinensis, and 
one of the most widely enjoyed drinks.2,3 The leaves of the plant are rich in flavonoids, 
containing several phytochemicals including phenols and catechins, to which potent 
antioxidant, free radical scavenging, appetite-modifying and hypolipidemic effects have 
been ascribed.2-7 Long-term consumption of beverages containing catechins inhibits 
the formation of oxidized lipids and decreases body fat.5-9 Over 70% of flavonoids in 
green tea are catechins. Epigallocatechin-3-gallate (EGCG) is the cardinal (65%) 
catechin in green tea. In-vitro studies have shown that the epigallocatechins in green 
tea have angiotensin converting enzyme inhibitor properties,10 and vasodilatory actions. 
11 Molecular and animal studies have demonstrated that green tea catechins enhance 
processes, thought to stimulate bile acid production, decrease cholesterol concentration 
in the hepatocytes, inhibit intestinal absorption of lipids and upregulate low-density 
lipoprotein (LDL) receptors in the liver, mechanisms all leading to favorable blood 
lipid profile.2-4,12,13
Black tea also contains small amounts of catechins. However, due to the fermen-
tation process of black tea, its primary antioxidant polyphenols are theaflavins and 
thearubigins, equally effective antioxidants to catechins.14
Tea is the most widely consumed beverage by people across the globe, next to water. 
Tea is manufactured in three basic forms, green, black and oolong tea.6 All forms of tea 
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come from the leaves of the plant Camellia sinensis, however 
the processing that the leaves undergo to make the final tea 
is different. The leaves for black tea are fully oxidized, while 
those for green teas are lightly steamed before being dried, 
so that the oxidative enzymes are inactivated and the flavo-
noid contents are retained. Oolong tea is a partially oxidized 
product. Black tea represents approximately 72% of the total 
consumed tea in the world, whereas green tea accounts for 
20-25% and oolong tea for <2%. Green tea is rich in the 
flavanol group of polyphenols, known as catechins, which may 
constitute up to 30% of the dry leaf weight (Table 1). Other 
components include other polyphenols, caffeine (~3%), along 
with very small amounts of the other common methylxanthines, 
theobromine and theophylline. Thearubigins constitute the 
largest mass of the extractable matter in black tea. Oolong 
tea is intermediate in composition between green and black 
teas. Black teas mostly come from plantations in Africa, India, 
Sri Lanka and Indonesia, while green teas come from the Far 
East (China and Japan). As indicated above, black and green 
teas both contain similar amount of flavonoids, however they 
differ in their chemical structure. Green teas contain more of 
the simple flavonoids called catechins, while the oxidisation 
that the leaves undergo to make black tea converts these simple 
flavonoids to the more complex varieties called theaflavins 
and thearubigins. Although the oxidisation process modifies 
the type of flavonoids present, the total level and their overall 
antioxidant activity, is similar in both teas.14
Cardiovascular disease (CVD) is the leading cause of mor-
bidity and mortality in the industrialized world.15 According to 
World Health Organization report, CVDs were accounted for 
29% of all global deaths in 2004 and about 23.6 million people 
will die from CVDs by 2030.2 In the USA, CVD accounted 
for 32% of all deaths in 2010 and more than one third of the 
U.S. population live with >1 types of CVD.15 By 2030, 44% of 
the US population is projected to have some form of CVD. In 
most instances, CVD is attributed to atherosclerosis, a vascular 
chronic athero-thrombo-inflammatory condition.16
The cardiovascular effects of green tea consumption have 
been extensively studied in human as well as in animal models.2 
There is accumulating evidence from epidemiological and 
human interventional studies that consumption of green tea 
is associated with decreased CVD risks.17-22
To date, many of the catechins’ effects have been demon-
strated, although the exact underlying mechanisms have not 
been fully elucidated. The most important biological actions 
are their antioxidant and free radical scavenging proper-
ties.23 In addition to their direct antioxidant effect, they can 
also indirectly increase endogenous antioxidants to mitigate 
oxidative damage. Catechins can also protect cells from lipid 
peroxidation and DNA deamination induced by oxidative 
stress. Epigallocatechin gallate (EGCG) has been shown to 
modulate apoptotic pathways to protect against oxidative 
stress. Catechins can also modulate apoptosis by altering 
antiapoptotic and proapoptotic gene expression. However, 
a divergent effect of catechins on apoptotic pathways may 
exist, as in low concentrations catechins may demonstrate 
antiapoptotic effects, while high doses may promote apoptosis. 
Similarly, in addition to the evidence of catechin-conferred 
cytoprotection via antioxidant and antiapoptotic actions, other 
observations suggest that catechins may also be prooxidant, 
mostly at high concentrations. However, the prooxidant ef-
fects of high-dose catechins may induce an up-regulation of 
endogenous antioxidants, which may enhance cytoprotection. 
Additionally, catechins appear to have anti-inflammatory ef-
fects,18 partly due to their scavenging of nitric oxide (NO) and 
reduction of NO synthase (NOS) activity, and/or the inhibition 
of inducible NOS (iNOS).
The antilipidemic properties of catechins have been well-
documented and can lead to CVD prevention. They have 
been shown to inhibit the oxidative modification of LDL.13 
Furthermore, catechins can inhibit LDL-induced human 
vascular smooth muscle proliferation, which is associated with 
atherogenesis.2,24,25
In vitro and in vivo studies have suggested potential anti-
platelet and antithrombotic effects of tea catechins.2 Exposure 
of human platelet concentrates to EGCG has been shown to 
maintain platelet aggregability and preserve platelets by inhib-
iting platelet activation and apoptosis. There is accumulating 
evidence that tea catechin supplementation may improve plate-
let aggregation and thrombosis through diverse mechanisms.
Finally, catechins have proven efficacy as prophylactic 
and neuroprotective agents against neurodegenerative/
neuroinflammatory diseases such as Parkinson’s disease, 
Alzheimer’s disease and multiple sclerosis, primarily due to 
their antioxidant and anti-inflammatory properties.23 They are 
also potent agents in preventing the neuronal damage that 
occurs after a stroke.23
Many cell culture and animal studies have shown that 
catechins are potent natural inhibitors of several tyrosine 
kinase receptors (RTKs).24 Enhanced RTK activity has been 
associated with the development of proliferative diseases such 
tAbLE 1. Components of Tea
black tea Green tea
Catechins 3-10% 30-42%
Flavonols 6-8% 5-10%
Theaflavins 3-6%
Thearubigins 12-18%
Methylxanthines 8-11% 7-9%
Carbohydrates 15% 10-15%
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as atherosclerosis and cancer. Hence, catechins, which inhibit 
the growth factor-RTK-mediated signal transduction pathways 
and exert an antiproliferative/antiapoptotic effect, can have 
a role in the prevention and management of such diseases.
Case-control, epidemiological, and small randomized 
controlled studies and several meta-analyses and reviews have 
suggested that tea intake has a cardioprotective effect, with 
beneficial effect on blood pressure, insulin resistance, inflam-
mation and oxidative stress, and on lipid profile in patients 
with cardiovascular disease.13,19-22,25-27
In a Polish double-blind, placebo-controlled trial, 56 obese, 
hypertensive patients were randomized to receive a daily sup-
plement of 1 capsule that contained either 379 mg of green tea 
extract or a matching placebo, for 3 months.18 According with 
these results, daily supplementation with 379 mg of green tea 
extract favorably influenced blood pressure, insulin resistance, 
inflammation and oxidative stress, and lipid profile in this 
small cohort of patients with obesity-related hypertension.18
According to a Japanese study, men who drank >4 cups 
of green tea per day exhibited an inverse association with 
coronary atherosclerosis.19 The favorable effect of catechins on 
vascular diseases has been ascribed, in part, to the catechins’ 
antioxidant properties that prevent low-density lipoprotein 
(LDL) oxidation.20
A meta-analysis of 20 randomized controlled trials 
comprising 1536 subjects revealed a significant, albeit small, 
reduction in systolic blood pressure conferred by green tea 
(mean difference - MD: -1.94 mmHg; p=0.0002).21 Similar 
results were also observed for total cholesterol (MD: -0.13 
mmol/l; p <0.0001) and LDL cholesterol (MD: -0.19 mmol/l; 
p=0.0004). The authors concluded that green tea intake re-
sults in significant reductions in systolic blood pressure, total 
cholesterol, and LDL cholesterol.
Another recent meta-analysis of 13 randomized controlled 
trials evaluating the effects of green tea on blood pressure 
in 1,367 subjects suggested that green tea consumption sig-
nificantly decreased systolic (by -1.98 mmHg; P <0.001), and 
diastolic blood pressure (by -1.92 mmHg; P=0.002), compared 
with the control group.22 Subgroup analyses suggested that the 
positive effect of green tea polyphenols on blood pressure was 
only showed in studies using a low-dose green tea polyphenol, 
and with long-term tea intake, and in those studies which 
excluded the confounding effects of caffeine. The authors 
concluded that low-dose long-term green tea consumption 
had a favorable effect on blood pressure.
A recent meta-analysis of 11 studies examined the effect 
of black tea (4-5 cups/day) on blood pressure in 378 patients.26 
The pooled mean effect of regular tea ingestion was -1.8 
mmHg (P=0.0013) for systolic and -1.3 mmHg (P <0.0001) 
for diastolic blood pressure. In covariate analyses, studies 
using tea extract powders found larger reductions in systolic 
blood pressure than studies using leaf tea. Baseline systolic 
and diastolic blood pressure had a significant impact on the 
effect of tea ingestion on blood pressure, with a ~1 mmHg 
larger reduction for every 10 mmHg higher baseline blood 
pressures. The authors concluded that regular consumption 
of black tea can reduce blood pressure.
In a review of 11 randomized controlled trials with a total 
of 821 individuals, 7 trials examining intake of green tea and 4 
trials examining intake of black tea, the results suggested that 
tea has favourable effects on CVD risk factors.3 Black tea was 
found to produce significant reductions in LDL cholesterol 
(MD, 0.43 mmol/L) and blood pressure (systolic blood pressure 
–SBP: MD -1.85 mmHg; diastolic blood pressure - DBP:MD 
-1.27 mmHg) over 6 months. Green tea was also found to 
produce significant reductions in total cholesterol (MD -0.62 
mmol/L), LDL cholesterol (MD -0.64 mmol/L) and blood pres-
sure (SBP: MD -3.18 mmHg; DBP: MD -3.42). When both tea 
types were analyzed together, they showed favourable effects 
on LDL cholesterol (MD -0.48 mmol/L) and blood pressure 
(SBP: MD -2.25 mmHg; DBP: MD -2.81 mmHg).
In another recent meta-analysis of 21 randomized con-
trolled trials examining the effects of tea intake on blood 
pressure in 1323 subjects, the mean systolic and diastolic blood 
pressures were -1.8 mmHg and -1.4 mmHg lower, respectively, 
in individuals drinking tea compared with the controls.27 Sub-
group analyses showed that the blood pressure-lowering effect 
was apparent in the subjects who consumed tea over a median 
of 12 weeks and for both green and black types of tea. The 
authors concluded that long-term (>12 weeks) ingestion of 
a tea (green and black tea) resulted in a significant reduction 
in systolic and diastolic blood pressure.
A final word of caution relates to usage of green tea extract 
capsules containing very high doses of polyphenols and EGCG 
(up to 750 mg of polyphenols per tablet) and involves liver 
toxicity.21,28 Recommended daily allowance should be limited 
to 10 mg of extract per kg of body weight with maximum dose 
of 750 mg/day. It is difficult to exceed the recommended daily 
allowance by drinking green tea. A cup of green tea contains 
on average only 80 mg of EGCG. In countries, like China, 
Japan, India, where people regularly drink 9–10 glasses of 
green tea a day, no cases of toxicity have been reported. Toxic-
ity involves only green tea extract capsules, and in most cases, 
liver function returns to normal upon discontinuation of high 
dosage of EGCG. According to randomized controlled stud-
ies, adverse events may occur where the daily intake of EGCG 
exceeded 200 mg. Animal and in vitro studies have shown 
that there could be an increased risk of adverse events when 
concentrated green tea is consumed on an empty stomach.21 
On the other hand, in vivo studies have shown that green tea 
consumption may be hepatoprotective, and pharmacokinetic 
studies in humans have demonstrated that green tea consump-
tion is quite safe.21
Although promising human and animal data have been 
accumulated indicating a cardioprotective effect of tea flavo-
noids, either green tea catechins or black tea thearubigins and 
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theaflavins, further rigorous and well-designed randomized 
controlled human interventional trials are needed to confirm 
and provide better understanding of the potential beneficial 
effects of tea on cardiovascular disease.
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